ZTS (STOCKS)
ZOETIS INC.
$75.651900
+2.111900 (+2.87%)
Prev close: $73.540000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kristin C. Peck
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $31,330.64M
- Employees
- 13,800
- P/E (TTM)
- 12.10
- P/B (TTM)
- 9.67
- Dividend Yield
- 284.20%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
11
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.87 | $1.87 | -0.0042 | -0.22% |
|
Mar 2026 (Q1)
|
$1.53 | $1.63 | -0.1009 | -6.19% |
|
Dec 2025 (Q4)
|
$1.48 | $1.42 | +0.0641 | +4.53% |
|
Sep 2025 (Q3)
|
$1.70 | $1.64 | +0.0621 | +3.79% |
Financial Statements
| Revenues | $9.52B |
| Benefits Costs and Expenses | $6.25B |
| Cost Of Revenue | $2.71B |
| Costs And Expenses | $6.25B |
| Gross Profit | $6.81B |
| Nonoperating Income/Loss | $47.00M |
| Operating Expenses | $3.54B |
| Selling, General, and Administrative Expenses | $2.38B |
| Other Operating Expenses | $1.16B |
| Operating Income/Loss | $3.27B |
| Income/Loss From Continuing Operations After Tax | $2.62B |
| Income/Loss From Continuing Operations Before Tax | $3.27B |
| Income Tax Expense/Benefit | $656.00M |
| Income Tax Expense/Benefit, Deferred | -$63.00M |
| Interest Expense, Operating | $238.00M |
| Net Income/Loss | $2.62B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $2.62B |
| Net Income/Loss Available To Common Stockholders, Basic | $2.62B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.09 |
| Diluted Earnings Per Share | $6.08 |
| Basic Average Shares | 1,280,843,000 |
| Diluted Average Shares | 1,281,535,000 |
| Assets | $15.08B |
| Current Assets | $6.36B |
| Inventory | $2.57B |
| Other Current Assets | $3.78B |
| Noncurrent Assets | $8.72B |
| Fixed Assets | $3.76B |
| Intangible Assets | $918.00M |
| Other Non-current Assets | $4.05B |
| Liabilities | $11.93B |
| Current Liabilities | $2.06B |
| Accounts Payable | $452.00M |
| Wages | $269.00M |
| Other Current Liabilities | $1.34B |
| Noncurrent Liabilities | $9.87B |
| Equity | $3.15B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.15B |
| Liabilities And Equity | $15.08B |
| Net Cash Flow From Operating Activities | $2.84B |
| Net Cash Flow From Operating Activities, Continuing | $2.84B |
| Net Cash Flow From Investing Activities | -$720.00M |
| Net Cash Flow From Investing Activities, Continuing | -$720.00M |
| Net Cash Flow From Financing Activities | -$2.28B |
| Net Cash Flow From Financing Activities, Continuing | -$2.28B |
| Exchange Gains/Losses | -$5.00M |
| Net Cash Flow | -$167.00M |
| Net Cash Flow, Continuing | -$162.00M |
| Comprehensive Income/Loss | $2.67B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.67B |
| Other Comprehensive Income/Loss | $51.00M |